Feature | July 07, 2010| Dave Fornell

Thrombectomy to Treat Pulmonary Embolism

Pulmonary embolism (PE) is generally treated with blood thinners, but a more aggressive treatment may be required for massive PE in hemodynamically compromised patients, said Ali Amin, M.D., a vascular surgeon at The Read Hospital and Medical Center in Reading, Pa. In these unstable patients with respiratory distress and near death, he said the AngioJet could be used off-label as an emergency treatment.

“You can use AngioJet in these patients to remove the clot and save their lives,” Amin said. “In these situations, you are not looking to get a perfect picture, you just want to remove enough of the clot to improve the blood pressure and the oxygen saturation.”

Once most of thrombus is removed to improve these factors, he said it is best to stop and continue treating the patient medically. “Your goal is very limited. Once you get oxygen saturation up, your job is done,” he explained.

Peter Soukas, M.D., director of vascular medicine and assistant professor of medicine, Tufts University School of Medicine, St. Elizabeth’s Medical Center, Boston, urges caution with the use of AngioJet in this application. He said people can get very sick if it is used to break up clots in the pulmonary artery, due to the possibility of distal embolization, resulting in acute right ventricular failure. The lysis of red blood cells results in the sudden release of large amounts of adenosine, which may lead to profound bradycardia. For this reason, a temporary pacemaker wire is often used when treating large proximal PE with the AngioJet.

Ekos for Pulmonary Embolism

Ekos plans a randomized clinical trial, ULTIMA (the ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism) to show the clinical benefit of an endovascular device to treat acute submassive pulmonary embolism in comparison to anticoagulation therapy alone. Enrollment is expected to commence in 2010 and be completed by the beginning of 2011.

Pulmonary embolism occurs at a rate of approximately 24 per 100,000 people and accounts for up 150,000 to 500,000 deaths per year in the United States and Europe and affects more than 1.6 million patients annually. Serious pulmonary emboli interfere with the heart’s ability to pump blood into the lungs for oxygenation, causing acute strain of the right side of the heart and potentially causing death.
Current treatments typically involve aggressive anticoagulation or intravenous delivery of clot-dissolving, thrombolytic agents.

Related Content

Medtronic MindFrame Capture LP Revascularization Device Recalled.
News | Thrombectomy Devices | May 21, 2018
Medtronic and the U.S. Food and Drug Administration (FDA) announced a Class I Urgent Medical Device Recall of the...
Stryker Trevo Retriever Thrombectomy Device Approved for Stroke Treatment Up to 24 Hours
Technology | Thrombectomy Devices | February 15, 2018
The U.S. Food and Drug Administration (FDA) has expanded the indication for Stryker's Trevo Retriever as a front-line...
Brain-scan guided emergency stroke treatment can save more lives
News | Thrombectomy Devices | January 25, 2018
January 25, 2018 – Advances in brain imaging can identify a greater number of stroke patients who can receive therapy
global thrombectomy devices market, Allied Market Research report, 2022
News | Thrombectomy Devices | January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...
Neuravi, EmboTrap II stent retriever, thrombectomy device, acute stroke, European launch, CE Mark
News | Thrombectomy Devices | September 28, 2016
Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available...
Penumbra System, ACE68 Reperfusion Catheter, thrombectomy device, SNIS 2016, acute ischemic stroke patients
Technology | Thrombectomy Devices | July 27, 2016
July 27, 2016 — Penumbra Inc. announced U.S.
Boston Scientific, Fetch 2 aspiration catheter, Class 1 recall
News | Thrombectomy Devices | April 20, 2016
April 20, 2016 — Boston Scientific Corp. announced a U.S.
SITS Open trial, mechanical thrombectomy devices. pREset, stroke treatment
News | Thrombectomy Devices | March 08, 2016
March 8, 2016 — phenox GmbH announced participation in the SITS Open clinical trial, where pREset and pREset LITE ...
thrombus aspiration, STEMI patients, TCT 2015, TOTAL study
Feature | Thrombectomy Devices | October 20, 2015
A pair of studies presented at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium...
acute ischemic stroke, larger thrombi retrieval, improved neurological recovery, ESC 2015, MR CLEAN trial, sub-study
Feature | Thrombectomy Devices | September 02, 2015
Retrieval of larger thrombi during intra-arterial treatment (IAT) is associated with improved neurological recovery...
Overlay Init